Medication info

Bazetive Tablets 10/20 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Il Yang Biofarm Co., Ltd.
Appearance
White to off-white, biconvex, rectangular tablet
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Expired

MFDS item code 201902906 · Approved 2019.05.07

This product's status changed to Expired on 2024.05.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg to 10/40mg per day. The generally recommended initial dose is 10/20mg per day. Patients who require less LDL cholesterol reduction may start at 10/10mg per day. After starting this medicine or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks before adjusting the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be prescribed only to patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see section 1. Warnings in Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 5. General Precautions, Patients with Abnormal Liver Function in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see section 5. General Precautions in Precautions for Use). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See section 6. Interactions in Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Il Yang Biofarm Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication is used as an adjunct to dietary restrictions to decrease elevated total cholesterol, LDL-cholesterol, Apo B protein, and triglycerides in patients with primary hypercholesterolemia, especially heterozygous familial and non-familial hypercholesterolemia, and mixed hyperlipidemia. It is also administered in homozygous familial hypercholesterolemia when other treatments are ineffective or require assistance. This medication should be used alongside appropriate dietary measures and other non-pharmacological strategies, and it is vital to first identify and treat other diseases or medications causing dyslipidemia. Blood lipid levels should be regularly monitored to assess treatment efficacy. This medication helps reduce the risk of atherosclerotic vascular disease due to hypercholesterolemia. Therefore, it is effectively used for blood lipid control and cardiovascular disease prevention.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg to 10/40mg per day. The generally recommended initial dose is 10/20mg per day. Patients who require less LDL cholesterol reduction may start at 10/10mg per day. After starting this medicine or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks before adjusting the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be prescribed only to patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see section 1. Warnings in Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 5. General Precautions, Patients with Abnormal Liver Function in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see section 5. General Precautions in Precautions for Use). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See section 6. Interactions in Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication is used to lower blood cholesterol levels. Caution is needed as muscle problems may occur when taking this medication. If symptoms such as muscle pain or weakness appear, consult a doctor immediately. Individuals with liver dysfunction or liver disease should not take this medication and should undergo regular liver function tests. Women who are pregnant or breastfeeding should not use this medication. Women planning to become pregnant must consult a doctor. The risk of side effects may increase when this medication is taken with specific other medications; therefore, inform your doctor if you are taking any other drugs. Elderly patients or children, especially those under 10 years old, should consult a doctor before taking this medication. In case of overdose, there is no specific antidote, so appropriate treatment will be provided based on symptoms. During treatment with this medication, intake of specific foods or drinks such as grapefruit juice should be limited, and attention should be paid to drug interactions. Rarely, prolonged use of this medication may lead to pulmonary disease or allergic reactions, so if any unusual symptoms occur, consult medical staff immediately.

Side effects

  • myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 87 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • angioedema
  • rash
  • pancreatitis
  • nausea
  • cholelithiasis
  • cholecystitis
  • asthenia
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • pruritus
  • eczema
  • rash
  • muscle cramps
  • immune-mediated necrotizing myopathy
  • taste disturbances
  • oculomotor dysfunction
  • facial paresis
  • tremor
  • dizziness
  • sensory disturbances
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorders
  • anxiety
  • sleep disorders
  • depression
  • cognitive impairment
  • interstitial lung disease
  • anaphylaxis
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • erectile dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated gamma-GT
  • elevated bilirubin levels
  • thyroid dysfunction
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stool
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to keep it at room temperature between 1°C and 30°C, avoiding extremes of heat or cold.

Appearance and packaging

Appearance

White to off-white, biconvex, rectangular tablet

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.